UOC
SYRS

UBS O'Connor’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

UBS O'Connor’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-359,305
Closed -$773K – 537
2024
Q3 		$773K Buy
359,305
+81,202
+29% +$175K 0.02% 299
2024
Q2 		$1.44M Buy
278,103
+103,103
+59% +$532K 0.04% 241
2024
Q1 		$936K Buy
175,000
+45,000
+35% +$241K 0.03% 278
2023
Q4 		$1.01M Buy
+130,000
New +$1.01M 0.03% 264